216 related articles for article (PubMed ID: 37283257)
21. Hypofractionation for clinically localized prostate cancer.
Hickey BE; James ML; Daly T; Soh FY; Jeffery M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
[TBL] [Abstract][Full Text] [Related]
22. Influence of Hypofractionated Versus Conventional Fractionated Postmastectomy Radiation Therapy in Breast Cancer Patients With Reconstruction.
Kim DY; Park E; Heo CY; Jin US; Kim EK; Han W; Shin KH; Kim IA
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):445-456. PubMed ID: 34610389
[TBL] [Abstract][Full Text] [Related]
23. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR
Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109
[TBL] [Abstract][Full Text] [Related]
24. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
[TBL] [Abstract][Full Text] [Related]
25. Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study.
Chung SY; Chang JS; Shin KH; Kim JH; Park W; Kim H; Kim K; Lee IJ; Yoon WS; Cha J; Lee KC; Kim JH; Choi JH; Ahn SJ; Ha B; Lee SY; Lee DS; Lee J; Shin SO; Lee SW; Choi J; Kim MY; Kim YJ; Im JH; Suh CO; Kim YB
Breast; 2021 Apr; 56():7-13. PubMed ID: 33517043
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Koukourakis MI; Giatromanolaki A; Kouroussis C; Kakolyris S; Sivridis E; Frangiadaki C; Retalis G; Georgoulias V;
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):144-55. PubMed ID: 11777632
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up.
Eldeeb H; Awad I; Elhanafy O
Med Oncol; 2012 Dec; 29(4):2570-6. PubMed ID: 22354766
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
Nandi M; Mahata A; Mallick I; Achari R; Chatterjee S
Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
[TBL] [Abstract][Full Text] [Related]
29. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
Yadav BS; Sharma SC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
[TBL] [Abstract][Full Text] [Related]
30. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
Mutter RW; Giri S; Fruth BF; Remmes NB; Boughey JC; Harless CA; Ruddy KJ; McGee LA; Afzal A; Gao RW; Shumway DA; Vern-Gross TZ; Villarraga HR; Kenison SL; Kang Y; Wong WW; Stish BJ; Merrell KW; Yan ES; Park SS; Corbin KS; Vargas CE
Lancet Oncol; 2023 Oct; 24(10):1083-1093. PubMed ID: 37696281
[TBL] [Abstract][Full Text] [Related]
31. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
[TBL] [Abstract][Full Text] [Related]
32. Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series.
James M; Swadi S; Yi M; Johansson L; Robinson B; Dixit A
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):425-431. PubMed ID: 29436171
[TBL] [Abstract][Full Text] [Related]
33. Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters.
Brada M; Forbes H; Ashley S; Fenwick J
J Thorac Oncol; 2022 Apr; 17(4):532-543. PubMed ID: 35092841
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.
Ko DH; Norriss A; Harrington CR; Robinson BA; James ML
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):243-7. PubMed ID: 25287654
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Incrocci L; Wortel RC; Alemayehu WG; Aluwini S; Schimmel E; Krol S; van der Toorn PP; Jager H; Heemsbergen W; Heijmen B; Pos F
Lancet Oncol; 2016 Aug; 17(8):1061-1069. PubMed ID: 27339116
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
Chatterjee S; Chakraborty S;
Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
[TBL] [Abstract][Full Text] [Related]
39. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
[TBL] [Abstract][Full Text] [Related]
40. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]